Russell Investments Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.4M | Buy |
461,608
+84,671
| +22% | +$4.65M | 0.03% | 504 |
|
2025
Q1 | $26.6M | Buy |
376,937
+317,217
| +531% | +$22.4M | 0.04% | 498 |
|
2024
Q4 | $3.92M | Buy |
59,720
+14,198
| +31% | +$933K | 0.01% | 1296 |
|
2024
Q3 | $3.2M | Sell |
45,522
-11,998
| -21% | -$844K | ﹤0.01% | 1434 |
|
2024
Q2 | $4.75M | Sell |
57,520
-7,306
| -11% | -$604K | 0.01% | 1177 |
|
2024
Q1 | $5.68M | Buy |
64,826
+23,414
| +57% | +$2.05M | 0.01% | 1108 |
|
2023
Q4 | $4M | Buy |
41,412
+1,276
| +3% | +$123K | 0.01% | 1236 |
|
2023
Q3 | $3.55M | Sell |
40,136
-86,429
| -68% | -$7.65M | 0.01% | 1248 |
|
2023
Q2 | $11M | Sell |
126,565
-126,747
| -50% | -$11M | 0.02% | 739 |
|
2023
Q1 | $24.6M | Sell |
253,312
-42,790
| -14% | -$4.16M | 0.05% | 427 |
|
2022
Q4 | $30.6M | Buy |
296,102
+50,879
| +21% | +$5.26M | 0.06% | 373 |
|
2022
Q3 | $20.8M | Buy |
245,223
+154,900
| +171% | +$13.1M | 0.05% | 467 |
|
2022
Q2 | $7.51M | Buy |
90,323
+55,505
| +159% | +$4.61M | 0.02% | 892 |
|
2022
Q1 | $2.7M | Sell |
34,818
-4,728
| -12% | -$366K | ﹤0.01% | 1479 |
|
2021
Q4 | $3.51M | Sell |
39,546
-11,194
| -22% | -$992K | 0.01% | 1481 |
|
2021
Q3 | $3.91M | Buy |
50,740
+13,332
| +36% | +$1.03M | 0.01% | 1395 |
|
2021
Q2 | $3.12M | Buy |
37,408
+7,555
| +25% | +$630K | 0.01% | 1648 |
|
2021
Q1 | $2.25M | Sell |
29,853
-26,362
| -47% | -$1.98M | ﹤0.01% | 1817 |
|
2020
Q4 | $4.92M | Sell |
56,215
-2,333
| -4% | -$204K | 0.01% | 1246 |
|
2020
Q3 | $4.45M | Sell |
58,548
-18,630
| -24% | -$1.42M | 0.01% | 1204 |
|
2020
Q2 | $9.5M | Buy |
77,178
+59,355
| +333% | +$7.3M | 0.02% | 759 |
|
2020
Q1 | $1.48M | Sell |
17,823
-560
| -3% | -$46.4K | ﹤0.01% | 1632 |
|
2019
Q4 | $1.55M | Hold |
18,383
| – | – | ﹤0.01% | 1877 |
|
2019
Q3 | $1.25M | Sell |
18,383
-28,705
| -61% | -$1.95M | ﹤0.01% | 1897 |
|
2019
Q2 | $4.01M | Buy |
47,088
+8,825
| +23% | +$751K | 0.01% | 1343 |
|
2019
Q1 | $3.39M | Buy |
38,263
+12,628
| +49% | +$1.12M | 0.01% | 1445 |
|
2018
Q4 | $2.16M | Sell |
25,635
-6,001
| -19% | -$506K | ﹤0.01% | 1577 |
|
2018
Q3 | $3.08M | Sell |
31,636
-11,466
| -27% | -$1.12M | 0.01% | 1531 |
|
2018
Q2 | $4.03M | Buy |
43,102
+10,634
| +33% | +$994K | 0.01% | 1389 |
|
2018
Q1 | $2.63M | Sell |
32,468
-75,362
| -70% | -$6.09M | ﹤0.01% | 1682 |
|
2017
Q4 | $9.76M | Sell |
107,830
-119,061
| -52% | -$10.8M | 0.02% | 1010 |
|
2017
Q3 | $21.1M | Buy |
226,891
+192,532
| +560% | +$17.9M | 0.04% | 609 |
|
2017
Q2 | $3.12M | Sell |
34,359
-89,473
| -72% | -$8.13M | 0.01% | 1482 |
|
2017
Q1 | $10.9M | Buy |
123,832
+99,834
| +416% | +$8.76M | 0.02% | 829 |
|
2016
Q4 | $2M | Buy |
+23,998
| New | +$2M | ﹤0.01% | 1794 |
|